Pompe disease, also known as glycogen storage disease type II, is a rare genetic disorder that affects approximately 1 in...
INTRODUCTION Dr. Ahmed Farrag is a hematology and internal medicine specialist at the Thalassemia Centre at Latifa Women and Children...
The Food and Drug Administration (FDA) approved AstraZeneca's tremelimumab in combination with durvalumab and platinum-based chemotherapy for adult patients with...
GE Healthcare received FDA 510(k) clearance to add 3D imaging capabilities and PROPELLER technology as extensions to their AIR Recon...
Genentech has agreed to a multi-year collaboration with Arsenal Biosciences Inc. to develop next-generation T cell therapies for solid tumors....
Scribe Therapeutics Inc. and Sanofi have entered into a strategic collaboration to develop novel Natural Killer (NK) cell therapies for...
GlaxoSmithKline (GSK) plc and Spero Therapeutics, Inc. announced entering into a license agreement for tebipenem pivoxil hydrobromide (tebipenem HBr), a...
Oxford Immunotec, a Perkin Elmer company, received FDA approval to use T-Cell Select with its in vitro diagnostics tuberculosis (TB)...
After grabbing FDA approval in June, Alnylam Pharmaceuticals has recently received European Commission approval to market AMVUTTRA in the EU....
Novo Nordisk has entered into a definitive agreement with Forma Therapeutics to buy all its outstanding shares, USD 20 per...
